Open Label Multicenter Study, 52 Weeks Duration, Using Pimecrolimus Cream 1% for the Long-term Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Patients Within a Usual Clinical Setting.
Phase of Trial: Phase IV
Latest Information Update: 31 Mar 2017
At a glance
- Drugs Pimecrolimus (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Novartis
- 22 Nov 2007 Status changed from in progress to completed.
- 24 Aug 2007 New trial record.